This review demonstrates glycosylation's impact on immune regulation and gut health in host-bacteria interactions, suggesting implications for chronic inflammatory disorders.
Commensal bacteria produce a diverse array of glycosylated molecules, including glycoproteins, glycolipids, peptidoglycan, capsular polysaccharides, and exopolysaccharides, which play fundamental roles in host-microbe interactions. Recent advances have highlighted the intricate mechanisms by which bacterial glycosylation contributes to immune regulation, epithelial barrier integrity, and microbial community stability, with implications for a range of conditions, including infectious diseases, chronic inflammatory disorders such as inflammatory bowel disease (IBD) and Alzheimer's disease, and metabolic diseases such as diet-induced obesity. This review provides a comprehensive synthesis of historical and recent insights into commensal bacterial glycosylation, emphasizing its role as a key mediator of host-bacteria interactions and its broader impact on gut homeostasis and systemic health.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: